av/glaxosmithkline--big.svg

NSE:GLAXO

GlaxoSmithKline Pharmaceuticals Limited

  • Stock

INR

Last Close

2,964.60

02/05 08:51

Market Cap

431.92B

Beta: 0.09

Volume Today

152.98K

Avg: 51.02K

PE Ratio

64.03

PFCF: 16,370.88

Dividend Yield

1.31%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
3.61B
-
4.51B
24.76%
4.76B
5.57%
4.63B
2.70%
4.93B
6.55%
4.85B
1.74%
5.15B
6.21%
5.41B
5.02%
4.97B
8.02%
4.93B
0.97%
5.03B
2.21%
average payables
2.99B
-
3.54B
18.53%
3.40B
4.11%
3.92B
15.55%
4.56B
16.17%
3.82B
16.26%
4.11B
7.68%
5.18B
25.91%
4.99B
3.54%
5.27B
5.50%
6.67B
26.63%
average receivables
2.46B
-
2.80B
13.98%
3.28B
17.04%
3.69B
12.50%
3.84B
4.30%
2.94B
23.60%
3.68B
25.45%
3.90B
5.79%
2.29B
41.13%
2.07B
9.70%
2.57B
24.17%
book value per share
288.55
-
100.12
65.30%
118.46
18.32%
121.44
2.52%
126.31
4.01%
107.47
14.92%
88.49
17.66%
157.19
77.64%
102.79
34.61%
104.93
2.08%
115.20
9.78%
capex per share
-13.71
-
-17.97
31.04%
-23.81
32.51%
-17.19
27.79%
-9.20
46.48%
-2.61
71.63%
-2.04
21.67%
-2.60
27.14%
1.84
170.89%
1.36
26.26%
capex to depreciation
-9.38
-
-11.55
23.23%
-10.62
8.09%
-5.99
43.55%
-1.89
68.54%
-0.56
70.42%
-0.51
8.93%
-0.67
31.80%
0.45
166.92%
0.34
23.08%
capex to operating cash flow
-1.67
-
-1.29
22.71%
-0.85
33.86%
-0.73
14.52%
-0.32
56.42%
-0.08
75.92%
-0.04
44.17%
-0.09
112.86%
0.05
158.98%
0.02
66.73%
capex to revenue
-0.08
-
-0.10
24.51%
-0.14
34.21%
-0.09
33.72%
-0.05
48.08%
-0.01
71.40%
-0.01
23.57%
-0.01
28.16%
0.01
166.75%
0.01
32.08%
cash per share
230.83
-
78.08
66.18%
53.61
31.34%
50.65
5.52%
67.75
33.77%
62.68
7.49%
67.13
7.10%
171.35
155.25%
106.96
37.58%
109.61
2.48%
148.87
35.82%
days of inventory on hand
143.95
-
104.89
27.13%
137.49
31.08%
122.93
10.59%
126.15
2.63%
143.08
13.41%
134.63
5.90%
130.67
2.94%
134.97
3.30%
126.42
6.34%
days payables outstanding
109.55
-
68.71
37.28%
139.05
102.38%
102.54
26.26%
93.39
8.92%
121.56
30.16%
143.66
18.18%
121.52
15.41%
160.77
32.30%
185.87
15.61%
days sales outstanding
42.71
-
41.64
2.50%
51.52
23.72%
42.42
17.67%
25.34
40.25%
58.54
130.99%
29.68
49.29%
21.59
27.25%
23.47
8.68%
28.48
21.36%
debt to assets
0.00
-
0.00
19.37%
0.00
31.84%
0.00
52.82%
0.00
40.51%
0.01
8,852.27%
0.01
16.65%
0.00
61.04%
0.00
7.81%
0.00
-
debt to equity
0.00
-
0.00
9.76%
0.00
43.19%
0.00
39.51%
0.00
43.32%
0.02
8,335.03%
0.02
0.51%
0.01
67.36%
0.01
18.37%
0.01
-
dividend yield
0.02
-
0.02
11.19%
0.01
21.73%
0.01
5.57%
0.02
18.12%
0.03
74.55%
0.02
35.38%
0.07
278.88%
0.02
76.32%
0.02
1.74%
earnings yield
0.01
-
0.01
24.23%
0.02
35.85%
0.02
2.79%
0.00
78.37%
0.01
235.36%
0.01
8.11%
0.03
101.81%
0.02
35.57%
0.02
11.65%
enterprise value
143.96B
-
309.92B
115.28%
231.08B
25.44%
165.51B
28.38%
219.18B
32.43%
212.38B
3.10%
240.37B
13.18%
279.72B
16.37%
224.22B
19.84%
336.04B
49.87%
459.91B
36.86%
enterprise value over ebitda
51.50
-
46.99
8.77%
29.41
37.41%
31.24
6.21%
33.94
8.65%
28.59
15.76%
33.41
16.85%
24.78
25.83%
37.87
52.85%
39.06
3.14%
ev to operating cash flow
222.66
-
97.92
56.02%
35.01
64.25%
54.88
56.77%
43.30
21.10%
41.59
3.94%
34.50
17.05%
46.30
34.21%
57.74
24.69%
35.65
38.25%
ev to sales
11.21
-
7.95
29.16%
5.76
27.45%
7.01
21.56%
6.59
5.99%
7.51
14.08%
8.53
13.56%
6.90
19.19%
9.73
41.10%
12.27
26.08%
free cash flow per share
-5.50
-
-4.04
26.52%
4.10
201.43%
6.38
55.73%
19.75
209.54%
31.50
59.50%
45.81
45.42%
25.99
43.28%
32.51
25.12%
74.79
130.03%
free cash flow yield
-0.00
-
-0.00
2.13%
0.00
232.33%
0.00
26.05%
0.02
219.93%
0.02
39.20%
0.03
25.69%
0.02
28.63%
0.02
16.55%
0.03
63.34%
graham net net
181.81
-
28.23
84.47%
22.02
22.01%
-28.22
228.17%
-6.36
77.45%
9.23
245.00%
10.69
15.82%
82.62
673.12%
35.47
57.07%
29.92
15.64%
48.72
62.82%
graham number
223.85
-
230.20
2.84%
237.85
3.32%
273.35
14.93%
115.34
57.80%
205.17
77.88%
281.95
37.43%
288.75
2.41%
286.75
0.69%
376.74
31.39%
income quality
0.24
-
0.51
110.13%
0.91
78.58%
0.61
32.55%
0.76
24.09%
0.80
5.46%
0.33
59.02%
0.58
75.71%
0.99
71.44%
1.39
40.96%
intangibles to total assets
0.67
-
0
100%
0.01
Infinity%
0.02
71.51%
0.02
8.99%
0.02
5.55%
0.01
11.99%
0.01
46.54%
0.01
37.64%
0.01
35.38%
0.00
51.00%
interest coverage
1.10K
-
1.57K
42.58%
2.78K
76.70%
1.18K
57.54%
85.73
92.72%
215.63
151.52%
385.32
78.69%
463.64
20.32%
756.21
63.11%
1.36K
79.55%
interest debt per share
0.37
-
0.16
55.15%
0.11
33.97%
0.07
36.15%
0.07
3.46%
2.84
4,135.95%
2.25
20.79%
1.30
42.15%
1.02
21.39%
0.11
89.63%
0.66
526.07%
inventory turnover
2.54
-
3.48
37.24%
2.65
23.71%
2.97
11.85%
2.89
2.56%
2.55
11.83%
2.71
6.28%
2.79
3.03%
2.70
3.19%
2.89
6.76%
invested capital
0.00
-
0.00
9.76%
0.00
43.19%
0.00
39.51%
0.00
43.32%
0.02
8,335.03%
0.02
0.51%
0.01
67.36%
0.01
18.37%
16.08B
180,151,674,669,655.47%
18.02B
12.08%
market cap
145.08B
-
323.12B
122.72%
232.47B
28.05%
178.20B
23.35%
220.16B
23.55%
213.01B
3.25%
244.07B
14.58%
282.38B
15.70%
224.41B
20.53%
336.49B
49.94%
473.84B
40.82%
net current asset value
17.94B
-
8.22B
54.17%
6.76B
17.82%
2.91B
56.88%
2.35B
19.45%
4.60B
96.01%
5.88B
27.92%
17.38B
195.34%
9.09B
47.69%
10.19B
12.15%
12.53B
22.92%
net debt to ebitda
-2.19
-
-0.28
87.09%
-2.26
696.04%
-0.14
93.79%
-0.10
28.10%
-0.44
338.03%
-0.32
27.89%
-0.02
93.25%
-0.05
139.23%
-1.18
2,207.91%
net income per share
22.24
-
19.88
10.62%
20.70
4.13%
26.29
26.99%
5.50
79.07%
21.14
284.26%
22.48
6.32%
36.05
60.39%
34.83
3.40%
54.76
57.24%
operating cash flow per share
8.22
-
13.93
69.55%
27.91
100.34%
23.58
15.53%
28.95
22.82%
34.11
17.82%
47.86
40.29%
28.58
40.27%
34.36
20.19%
76.15
121.65%
payables turnover
3.33
-
5.31
59.45%
2.62
50.59%
3.56
35.61%
3.91
9.80%
3.00
23.17%
2.54
15.38%
3.00
18.21%
2.27
24.41%
1.96
13.50%
receivables turnover
8.55
-
8.76
2.57%
7.08
19.17%
8.60
21.46%
14.40
67.38%
6.24
56.71%
12.30
97.21%
16.90
37.46%
15.55
7.98%
12.82
17.60%
research and ddevelopement to revenue
0.00
-
return on tangible assets
0.12
-
0.11
8.38%
0.09
20.14%
0.12
27.95%
0.03
73.92%
0.12
286.25%
0.08
29.03%
0.19
124.02%
0.17
9.97%
0.23
35.66%
revenue per share
163.13
-
171.69
5.25%
169.50
1.27%
184.65
8.94%
190.33
3.08%
188.83
0.79%
193.50
2.47%
191.95
0.80%
203.87
6.21%
221.34
8.57%
roe
0.22
-
0.17
24.46%
0.17
1.58%
0.21
22.10%
0.05
75.40%
0.24
366.68%
0.14
40.15%
0.35
145.28%
0.33
5.37%
0.48
43.23%
roic
0.18
-
0.13
27.51%
0.17
28.57%
0.20
20.21%
0.09
56.32%
0.32
263.27%
0.14
55.97%
0.34
147.34%
0.55
60.79%
0.59
7.12%
sales general and administrative to revenue
0.00
-
0.00
19.36%
0.01
569.91%
0.01
30.96%
0.01
40.36%
0.01
9.20%
0.01
125.04%
0.01
30.92%
0.01
56.87%
shareholders equity per share
288.55
-
100.12
65.30%
118.46
18.32%
121.44
2.52%
126.31
4.01%
107.47
14.92%
88.49
17.66%
157.19
77.64%
102.79
34.61%
104.93
2.08%
115.20
9.78%
stock based compensation to revenue
0.00
-
tangible asset value
2.92B
-
16.96B
480.40%
19.75B
16.42%
19.85B
0.51%
20.74B
4.52%
17.71B
14.62%
14.56B
17.80%
26.28B
80.56%
17.07B
35.05%
17.54B
2.75%
19.38B
10.48%
tangible book value per share
288.55
-
100.12
65.30%
116.56
16.42%
117.15
0.51%
122.44
4.52%
107.47
12.23%
85.93
20.04%
155.16
80.56%
100.78
35.05%
103.54
2.74%
114.41
10.49%
working capital
20.74B
-
11.15B
46.26%
9.52B
14.55%
5.82B
38.93%
5.52B
5.12%
7.51B
36.03%
8.70B
15.93%
20.10B
130.94%
11.68B
41.88%
12.73B
9.04%
15.05B
18.16%

All numbers in INR (except ratios and percentages)